Bayesian models to estimate causal effects of biological
treatments on time-to-event endpoints in clinical trials with principal
strata defined by the occurrence of antidrug antibodies.
The methodology is based on Frangakis and Rubin (2002)
<doi:10.1111/j.0006-341x.2002.00021.x> and Imbens and Rubin (1997)
<doi:10.1214/aos/1034276631>, and here adapted to a specific
time-to-event setting.
| Version: |
0.0.7 |
| Depends: |
R (≥ 3.4.0) |
| Imports: |
dplyr, furrr, magrittr, methods, purrr, Rcpp (≥ 0.12.0), RcppParallel (≥ 5.0.1), rstan (≥ 2.18.1), rstantools (≥
2.4.0), stats, stringr, tibble |
| LinkingTo: |
BH (≥ 1.66.0), Rcpp (≥ 0.12.0), RcppEigen (≥ 0.3.3.3.0), RcppParallel (≥ 5.0.1), rstan (≥ 2.18.1), StanHeaders (≥
2.18.0) |
| Suggests: |
spelling |
| Published: |
2024-04-13 |
| Author: |
Christian Stock 
[aut, cre],
Emma Torrini [aut],
Boehringer Ingelheim Pharma GmbH & Co. KG [cph, fnd] |
| Maintainer: |
Christian Stock <christian.stock at boehringer-ingelheim.com> |
| BugReports: |
https://github.com/Boehringer-Ingelheim/BPrinStratTTE/issues |
| License: |
GPL (≥ 3) |
| URL: |
https://github.com/Boehringer-Ingelheim/BPrinStratTTE,
https://boehringer-ingelheim.github.io/BPrinStratTTE/ |
| NeedsCompilation: |
yes |
| SystemRequirements: |
GNU make |
| Language: |
en-US |
| Materials: |
README NEWS |
| CRAN checks: |
BPrinStratTTE results |